1,2-dihydroxybenzene-3,5-disulfonic acid disodium salt has been researched along with Cancer of Lung in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jensen, RT; Moody, TW; Ramos-Alvarez, I | 1 |
| Jensen, RT; Moody, TW; Moreno, P; Nuche-Berenguer, B | 1 |
| Han, YH; Park, WH | 1 |
| Liebes, L; Ling, YH; Perez-Soler, R; Zou, Y | 1 |
4 other study(ies) available for 1,2-dihydroxybenzene-3,5-disulfonic acid disodium salt and Cancer of Lung
| Article | Year |
|---|---|
Adding of neurotensin to non-small cell lung cancer cells increases tyrosine phosphorylation of HER3.
Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Acetylcysteine; Antibodies, Monoclonal; Antioxidants; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; ErbB Receptors; Humans; Lung Neoplasms; Matrix Metalloproteinase Inhibitors; Neuregulins; Neurotensin; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptor, ErbB-3; Receptors, Neurotensin; Superoxides; Tyrosine | 2022 |
CI-988 Inhibits EGFR Transactivation and Proliferation Caused by Addition of CCK/Gastrin to Lung Cancer Cells.
Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dipeptides; ErbB Receptors; Gastrins; Gefitinib; Hormone Antagonists; Humans; Indoles; Lung Neoplasms; Meglumine; Pyrimidines; Quinazolines | 2015 |
Tiron, a ROS scavenger, protects human lung cancer Calu-6 cells against antimycin A-induced cell death.
Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Antimycin A; Apoptosis; Catalase; Cell Line, Tumor; Free Radical Scavengers; Glutathione; Humans; Lung Neoplasms; Membrane Potential, Mitochondrial; Reactive Oxygen Species; Superoxide Dismutase | 2009 |
Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to Bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells.
Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Antineoplastic Agents; Antioxidants; Apoptosis; Boronic Acids; Bortezomib; Carcinoma, Non-Small-Cell Lung; Caspase Inhibitors; Cell Survival; Cysteine Endopeptidases; Cytochrome c Group; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Immunoblotting; Indicators and Reagents; Lung Neoplasms; Membrane Potentials; Mitochondria; Models, Chemical; Multienzyme Complexes; Protease Inhibitors; Proteasome Endopeptidase Complex; Pyrazines; Reactive Oxygen Species; Time Factors; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2003 |